Find clinical trials for Multiple Myeloma in Jacksonville, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Jacksonville, FL, USA:
A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
The purpose of this study is to evaluate three daratumumab dose schedules in participants with Smoldering Multiple Myeloma....
Phase 2
Jacksonville, Florida, United States and 56 other locations
This is a phase 1, multicenter, open-label study evaluating the safety and efficacy of ruxolitinib, steroids and lenalidomide among MM patients who c...
Phase 1
Jacksonville, Florida, United States and 12 other locations
versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM).The study is anticipated to randomize app...
Phase 3
Jacksonville, Florida, United States and 59 other locations
progression-free survival (PFS) in participants with newly diagnosed multiple myeloma (a blood cancer of plasma cells) who are not ...
Phase 3
Jacksonville, Florida, United States and 211 other locations
The purpose of this study is to evaluate the effectiveness and safety of BMS-986393 in participants with relapsed or refractory multiple myeloma...
Phase 2
Jacksonville, Florida, United States and 41 other locations
(LD-Dex) (Cohort B) in subjects with relapsed or refractory multiple myeloma who have received a first or second line treatment of ...
Phase 2
Jacksonville, Florida, United States and 48 other locations
with Relapsed/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM) administered according to different dosing sch...
Phase 1, Phase 2
Jacksonville, Florida, United States and 12 other locations
This is a global, open-label, multi-arm, multi-cohort, multi-center, phase 1/2 study to determine the safety, tolerability, efficacy, PK of bb2121 in...
Phase 1, Phase 2
Jacksonville, Florida, United States and 16 other locations
compared with VMP alone in participants with previously untreated multiple myeloma who are ineligible for high dose chemotherapy an...
Phase 3
Orange Park, Florida, United States and 164 other locations
and tolerable dose of BMS-986393 in combinations with alnuctamab, mezigdomide, and iberdomide in participants with relapsed and/or refractory multiple...
Phase 1
Jacksonville, Florida, United States and 18 other locations
Clinical trials
Research sites
Resources
Legal